Market Overview

UPDATE: Piper Jaffray Reiterates Overweight Rating, Raises PT on Cerner Corporation on Q4 Bookings

Share:
Related CERN
Fast Money Picks For February 17
Earnings Scheduled For February 10, 2015
Omnicell (OMCL) Falls: Stock Goes Down 6.1% - Tale of the Tape (Zacks)

In a report published Wednesday, Piper Jaffray reiterated its Overweight rating on Cerner Corporation (NASDAQ: CERN), and raised its price target from $84.00 to $100.00.

Piper Jaffray noted, “Cerner reported numbers that beat our and consensus estimates handily. Bookings of $1.02 billion was the highlight in the quarter, exceeding its own guidance despite not adding a single ITWorks and RevWorks contract. While the stimulus rush is helping the bookings growth right now, we believe the company is already establishing itself in data analytics, which is the next growth leg in Healthcare IT. We believe that healthcare data analytics is a huge developing market with very limited competition and early glimpses of the capabilities suggests that CERN will become a dominant player."

Cerner Corporation closed on Tuesday at $83.60.

Latest Ratings for CERN

DateFirmActionFromTo
Mar 2015Topeka CapitalDowngradesBuyHold
Feb 2015Deutsche BankMaintainsBuy
Feb 2015BarclaysMaintainsOverweight

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Price Target Analyst Ratings

 

Related Articles (CERN)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→